Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Potential use of MEN-10755 in recurrent non-small cell lung cancer

Oct. 31, 2002

Safety and efficacy of oral ibandronate in breast cancer-related bone events

Oct. 31, 2002

Promising safety results reported for CpG-7909 as adjuvant to antitumor vaccination

Oct. 31, 2002

Statin induces apoptosis in RA synoviocytes

Oct. 30, 2002

Potent and gut-selective Ca2+ channel antagonist with potential in IBS

Oct. 30, 2002

Inhibition of p38 MAP kinase associated with significant antiinflammatory effects in CIA

Oct. 30, 2002

New data on the efficacy and safety of valdecoxib

Oct. 30, 2002

Fluoroquinolone ABT-492 shows particularly promising activity against respiratory pathogens

Oct. 29, 2002

Sustained activity demonstrated for Albugranin in two animal species

Oct. 29, 2002

Favorable PK and drug interaction data reported for anidulafungin at IDSA

Oct. 29, 2002

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...